| |
By first event
|
---|
|
All patients ( N= 490)
|
Discharge ( N= 235)
|
Cardiac arrest ( N= 63)
|
Limitation in life support ( N= 192)
|
---|
Age
|
52 (42 to 62)
|
48 (40 to 59)
|
50 (41 to 63)
|
56 (48 to 66)
|
Female
|
43.5
|
46.0
|
41.3
|
41.1
|
Nonwhite
|
40.8
|
39.2
|
46.0
|
41.2
|
Oncology comorbidity
|
18.4
|
15
|
17
|
22
|
Charlson Comorbidity Index
|
2 (1 to 4)
|
1 (0 to 3)
|
3 (1 to 5)
|
3 (1 to 4)
|
Functional Comorbidity Index
|
1 (1 to 3)
|
1 (1 to 3)
|
1 (0 to 3)
|
1 (1 to 3)
|
Study site hospital
| | | | |
1
|
38.0
|
31.9
|
42.9
|
43.8
|
2
|
31.0
|
31.9
|
33.3
|
29.2
|
3
|
31.0
|
36.2
|
23.8
|
27.1
|
Days in hospital before ALI onset
|
2 (1 to 6)
|
2 (1 to 5)
|
2 (1 to 10)
|
3 (1 to 7)
|
Medical ICU
|
80.4
|
74.9
|
84.1
|
85.9
|
APACHE II score at ICU admission
|
26 (20 to 33)
|
23 (19 to 29)
|
33 (22 to 38)
|
29 (22 to 35)
|
SOFA score at ALI onset
|
9 (7 to 12)
|
8 (5 to 10)
|
12 (8 to 14)
|
11 (8 to 14)
|
Survival to ICU discharge
|
56.3
|
100.0
|
23.8
|
13.5
|
- Data presented as median (interquartile range) or percentage. ALI, Acute lung injury; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.